These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17688650)

  • 21. Antiepileptic drug use during pregnancy: perinatal outcomes.
    Kulaga S; Sheehy O; Zargarzadeh AH; Moussally K; Bérard A
    Seizure; 2011 Nov; 20(9):667-72. PubMed ID: 21763158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
    Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproate teratogenicity and epilepsy syndrome.
    Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
    Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fetal valproate syndrome].
    Taubøll E; Gjerstad L; Henriksen T; Husby H
    Tidsskr Nor Laegeforen; 2003 Oct; 123(19):2765. PubMed ID: 14600761
    [No Abstract]   [Full Text] [Related]  

  • 26. [Human teratogenicity of valproic acid containing antiepileptic drugs].
    Orv Hetil; 1982 Dec; 123(51):3170. PubMed ID: 6819505
    [No Abstract]   [Full Text] [Related]  

  • 27. The prescribing of antiepileptic drugs for pregnant Australian women.
    Vajda FJ; Horgan D; Hollingworth S; Graham J; Hitchcock AA; Roten A; O'Brien TJ; Lander CM; Eadie MJ
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):49-53. PubMed ID: 21910695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproate, women, and exceptional circumstances.
    Angus-Leppan H; Shankar R; Cock H;
    BMJ; 2018 Aug; 362():k3625. PubMed ID: 30154117
    [No Abstract]   [Full Text] [Related]  

  • 29. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foetal safety of old and new antiepileptic drugs.
    Verrotti A; Mencaroni E; Castagnino M; Zaccara G
    Expert Opin Drug Saf; 2015 Oct; 14(10):1563-71. PubMed ID: 26329145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring.
    Artama M; Auvinen A; Raudaskoski T; Isojärvi I; Isojärvi J
    Neurology; 2005 Jun; 64(11):1874-8. PubMed ID: 15955936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of fetal valproate syndrome with new features expanding the phenotype.
    Seidahmed MZ; Miqdad AM; Al-Dohami HS; Shareefi OM
    Saudi Med J; 2009 Feb; 30(2):288-91. PubMed ID: 19198722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple congenital malformations including generalized hypertrichosis with gum hypertrophy in a child exposed to valproic acid in utero.
    Stoll C; Audeoud F; Gaugler C; Bernardin A; Messer J
    Genet Couns; 2003; 14(3):289-98. PubMed ID: 14577673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs.
    Lindhout D; Omtzigt JG; Cornel MC
    Neurology; 1992 Apr; 42(4 Suppl 5):111-8. PubMed ID: 1574164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of epilepsy in women of child-bearing age and the Australian experience of valproate in pregnancy.
    Curran MA
    Clin Exp Neurol; 1987; 23():145-8. PubMed ID: 3117457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid use in pregnancy and congenital malformations.
    Vajda F; O'Brien T
    N Engl J Med; 2010 Oct; 363(18):1771; author reply 1771-2. PubMed ID: 20979483
    [No Abstract]   [Full Text] [Related]  

  • 37. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
    Omtzigt JG; Los FJ; Grobbee DE; Pijpers L; Jahoda MG; Brandenburg H; Stewart PA; Gaillard HL; Sachs ES; Wladimiroff JW
    Neurology; 1992 Apr; 42(4 Suppl 5):119-25. PubMed ID: 1574165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stigmata of dysembryogenesis and physical development in children born to mothers with epilepsy].
    Kozhokaru AB; Karlov VA; Zhidkova IA; Serkina AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5 Pt 2):52-7. PubMed ID: 23120790
    [No Abstract]   [Full Text] [Related]  

  • 39. Valproic acid: long-term effects on children exposed in utero.
    Prescrire Int; 2009 Dec; 18(104):253-7. PubMed ID: 20025093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.